Ad is loading...
IYBIX
Price
$23.77
Change
-$0.22 (-0.92%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

IYBIX vs RAMHX

Header iconIYBIX vs RAMHX Comparison
Open Charts IYBIX vs RAMHXBanner chart's image
Delaware Ivy Balanced Fund
Price$23.77
Change-$0.22 (-0.92%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
IYBIX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IYBIX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IYBIX is a StrongSell and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. IYBIX (1.56B). IYBIX pays higher dividends than RAMHX: IYBIX (2.28) vs RAMHX (1.84). IYBIX was incepted earlier than RAMHX: IYBIX (18 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. IYBIX (82.00). IYBIX has a lower initial minimum investment than RAMHX: IYBIX (0) vs RAMHX (250). IYBIX annual gain was more profitable for investors over the last year : 24.45 vs. RAMHX (20.31). RAMHX return over 5 years is better than : 32.43 vs. IYBIX (-0.79).
IYBIXRAMHXIYBIX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years10 years-
Gain YTD16.86113.582124%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B236B1%
Annual Yield % from dividends2.281.84124%
Returns for 1 year24.4520.31120%
Returns for 3 years-18.459.39-197%
Returns for 5 years-0.7932.43-2%
Returns for 10 years1.8346.744%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings